These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35647354)

  • 41. Management of Glioblastoma Multiforme by Phytochemicals: Applications of Nanoparticle-Based Targeted Drug Delivery System.
    Mumtaz SM; Bhardwaj G; Goswami S; Tonk RK; Goyal RK; Abu-Izneid T; Pottoo FH
    Curr Drug Targets; 2021; 22(4):429-442. PubMed ID: 32718288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma.
    Harder BG; Blomquist MR; Wang J; Kim AJ; Woodworth GF; Winkles JA; Loftus JC; Tran NL
    Front Oncol; 2018; 8():462. PubMed ID: 30406029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
    Fadera S; Chen PY; Liu HL; Lee IC
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32845-32855. PubMed ID: 34235925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment.
    Tang L; Feng Y; Gao S; Mu Q; Liu C
    Front Pharmacol; 2021; 12():786700. PubMed ID: 34899350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanoformulations for glioblastoma multiforme: a new hope for treatment.
    Ortiz R; Cabeza L; Perazzoli G; Jimenez-Lopez J; García-Pinel B; Melguizo C; Prados J
    Future Med Chem; 2019 Sep; 11(18):2459-2480. PubMed ID: 31544490
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The evolving role of antiangiogenic therapies in glioblastoma multiforme: current clinical significance and future potential.
    Anthony C; Mladkova-Suchy N; Adamson DC
    Expert Opin Investig Drugs; 2019 Sep; 28(9):787-797. PubMed ID: 31356114
    [No Abstract]   [Full Text] [Related]  

  • 48. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment.
    Pinel S; Thomas N; Boura C; Barberi-Heyob M
    Adv Drug Deliv Rev; 2019 Jan; 138():344-357. PubMed ID: 30414495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distance to the neurooncological center: a negative prognostic factor in patients with glioblastoma multiforme. An epidemiological study.
    Kerschbaumer J; Freyschlag CF; Bauer R; Obwegeser AA; Schubert GA; Thomé C; Seiz M
    Anticancer Res; 2012 Dec; 32(12):5515-9. PubMed ID: 23225460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma.
    Spencer D; Yu D; Morshed RA; Li G; Pituch KC; Gao DX; Bertolino N; Procissi D; Lesniak MS; Balyasnikova IV
    Theranostics; 2019; 9(7):2071-2083. PubMed ID: 31037157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
    da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Global Landscape of Glioblastoma Multiforme Management in the Stupp Protocol Era: Systematic Review Protocol.
    Adegboyega G; Kanmounye US; Petrinic T; Ozair A; Bandyopadhyay S; Kuri A; Zolo Y; Marks K; Ramjee S; Baticulon RE; Vaqas B;
    Int J Surg Protoc; 2021 Jun; 25(1):108-113. PubMed ID: 34222733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticancer drug-loaded hydrogels as drug delivery systems for the local treatment of glioblastoma.
    Bastiancich C; Danhier P; Préat V; Danhier F
    J Control Release; 2016 Dec; 243():29-42. PubMed ID: 27693428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
    Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
    Konar SK; Bir SC; Maiti TK; Nanda A
    J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reuse of Molecules for Glioblastoma Therapy.
    Koehler A; Karve A; Desai P; Arbiser J; Plas DR; Qi X; Read RD; Sasaki AT; Gawali VS; Toukam DK; Bhattacharya D; Kallay L; Pomeranz Krummel DA; Sengupta S
    Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33525329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The challenges of managing glioblastoma multiforme in developing countries: a trade-off between cost and quality of care.
    Salem A; Hashem SA; Al-Rashdan A; Ezam N; Nour A; Alsharbaji A; Sughayer M; Mohamad I; Elyan M; Addas A; Al-Hussaini M; Almousa A
    Hematol Oncol Stem Cell Ther; 2011; 4(3):116-20. PubMed ID: 21982884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.
    Agarwal S; Sane R; Oberoi R; Ohlfest JR; Elmquist WF
    Expert Rev Mol Med; 2011 May; 13():e17. PubMed ID: 21676290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of glioblastoma.
    Aoki T; Hashimoto N; Matsutani M
    Expert Opin Pharmacother; 2007 Dec; 8(18):3133-46. PubMed ID: 18035958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas.
    St-Coeur PD; Touaibia M; Cuperlovic-Culf M; Morin P
    Genomics Proteomics Bioinformatics; 2013 Aug; 11(4):199-206. PubMed ID: 23732626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.